U. Ringborg

R. Schilsky, A. Tsimberidou, U. Ringborg, 2013, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Mutations of PIK3CA are rare in cutaneous melanoma

J. Hansson, U. Ringborg, K. Omholt, 2006, Melanoma research.

Biallelic Deletions in INK4 in Cutaneous Melanoma Are Common and Associated with Decreased Survival

S. Egyházi, J. Hansson, U. Ringborg, 2005, Clinical Cancer Research.

Towards Quality, Comprehensiveness and Excellence. The Accreditation Project of the Organisation of European Cancer Institutes (OECI)

W. V. van Harten, A. Paradiso, T. Tursz, 2008 .

Towards quality, comprehensiveness and excellence. The accreditation project of the Organisation of European Cancer Institutes (OECI).

W. V. van Harten, A. Paradiso, T. Tursz, 2008, Tumori.

p53 protein expression and TP53 mutations in malignant melanomas of sun-sheltered mucosal membranes versus chronically sun-exposed skin

U. Ringborg, A. Platz, B. Ragnarsson-Olding, 2004, Melanoma research.

Need for global action for cancer control.

R. J. Thomas, H. Bartelink, A. Gavin, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Body site of cutaneous malignant melanoma – a study on patients with hereditary and multiple sporadic tumours

J. Hansson, U. Ringborg, J. Frisell, 2003, Melanoma research.

A new computerized methodology to analyse tumour site in relation to phenotypic traits and epidemiological characteristics of cutaneous malignant melanoma

J. Hansson, U. Ringborg, J. Frisell, 2002, The British journal of dermatology.

The association between anatomic site and survival in malignant melanoma. An analysis of 12,353 cases from the Swedish Cancer Registry.

U. Ringborg, R. Bergström, H. Adami, 1989, European journal of cancer & clinical oncology.

Hereditary cutaneous melanoma.

J. Hansson, U. Ringborg, A. Platz, 2000, Seminars in cancer biology.

Tobacco: deadly in any form or disguise

P. Boyle, K. Soo, A. Berns, 2006, The Lancet.

Malignant melanoma: aetiological importance of individual pigmentation and sun exposure

H. Beitner, U. Ringborg, S. Norell, 1990 .

N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin.

U. Ringborg, A. Platz, B. Ragnarsson-Olding, 1998, The Journal of investigative dermatology.

Genes involved in cell cycle G1 checkpoint control are frequently mutated in human melanoma metastases.

T. Norberg, U. Ringborg, A. Platz, 1996, British Journal of Cancer.

Curbing tobacco's toll starts with the professionals: World No Tobacco Day

H. Klocker, P. Boyle, A. Berns, 2005, The Lancet.

Cancer of the skin: a forgotten problem in Europe.

P. Boyle, U. Ringborg, J. Doré, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden.

U. Ringborg, T. Hakulinen, C. Wassberg, 1996, British Journal of Cancer.

Perceived susceptibility to and knowledge of malignant melanoma: screening participants vs the general population.

U. Ringborg, Y. Brandberg, P. Sjödén, 1996, Preventive medicine.

Screening for Cutaneous Malignant Melanoma: A Feasibility Study

U. Ringborg, Y. Brandberg, S. Törnberg, 1996, Journal of medical screening.

Malignant melanoma: aetiological importance of individual pigmentation and sun exposure.

H. Beitner, U. Ringborg, S. Norell, 1991, The British journal of dermatology.

Alcohol and risk of cancer.

U. Ringborg, 1998, Alcoholism, clinical and experimental research.

Swedish Oncology. Past – present – future

U. Ringborg, 2008, Acta oncologica.

Melanoma metastases from patients with hereditary cutaneous malignant melanoma contain a high frequency of N-ras activating mutations

U. Ringborg, A. Platz, B. Lagerlöf, 1994, Melanoma research.

Trends in survival from malignant melanoma: remarkable improvement in 23 years.

H. Adami, U. Ringborg, R. Bergström, 1989, Journal of the National Cancer Institute.

Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984.

U. Ringborg, R. Bergström, H. Adami, 1990, American journal of epidemiology.

Elective lymph node dissection in stage I cutaneous malignant melanoma of the head and neck. A report from the Swedish Melanoma Study Group

J. Wersäll, P. Hofer, J. Hansson, 1994, Melanoma research.

Second primary cancers in patients with squamous cell carcinoma of the skin: A population‐based study in Sweden

U. Ringborg, T. Hakulinen, C. Wassberg, 1999, International journal of cancer.

Contribution of glutathione transferase M3-3 to 1,3-bis(2-chloroethyl)-1-nitrosourea resistance in a human non-small cell lung cancer cell line.

S. Egyházi, J. Hansson, X. Hao, 1993, Cancer research.

Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells.

B. Nilsson, J. Hansson, M. Edgren, 1988, Cancer research.

Comparative study of two human melanoma cell lines with different sensitivities to mustine and cisplatin.

J. Hansson, M. Edgren, U. Ringborg, 1991, European journal of cancer.

Species-specific in vivo engraftment of the human BL melanoma cell line results in an invasive dedifferentiated phenotype not present in xenografts.

L. Kanter, J. Hansson, U. Ringborg, 2009, Cancer research.

Epidemiological characteristics of cutaneous malignant melanoma of the head and neck--a population-based study.

U. Ringborg, H. Johansson, J. Frisell, 1999, Acta oncologica.

Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: A clinic‐based population study

J. Hansson, U. Ringborg, A. Platz, 1998 .

Boosting the social impact of innovative cancer research – towards a mission‐oriented approach to cancer

A. Berns, A. Eggermont, C. Wild, 2019, Molecular Oncology.

Cancer Core Europe: A translational research infrastructure for a European mission on cancer

C. Caldas, G. Apolone, I. Ernberg, 2019, Molecular oncology.

Towards a Cancer Mission in Horizon Europe

D. Hanahan, D. Lacombe, A. Berns, 2019, Molecular oncology.

European Academy of Cancer Sciences – position paper

H. Adami, A. Harris, A. Berns, 2018, Molecular oncology.

Cancer Core Europe: A first step towards a virtual cancer institute in Europe?

U. Ringborg, J. Celis, 2014, Molecular oncology.

The Stockholm Declaration

U. Ringborg, 2008, Molecular oncology.

Personalized cancer medicine – A strategy to counteract an increasing cancer challenge

R. Schilsky, J. Mendelsohn, U. Ringborg, 2012, Molecular oncology.

U. Ringborg, B. Lambert, L. Skoog, 1979, Cancer research.

Repair of UV-induced DNA lesions in peripheral lymphocytes from healthy subjects of various ages, individuals with Down's syndrome and patients with actinic keratosis

U. Ringborg, B. Lambert, G. Swanbeck, 1977 .

Expression of class Pi glutathione transferase in human malignant melanoma cells.

J. Hansson, B. Mannervik, U. Ringborg, 1987, Carcinogenesis.

Increasing incidence rates of squamous cell carcinoma of the skin in Sweden.

U. Ringborg, B. Berne, C. Wassberg, 2001, Acta dermato-venereologica.

Different activities of unscheduled DNA synthesis in human melanoma and bone marrow cells.

R. Lewensohn, J. Hansson, U. Ringborg, 1982, Cancer research.

Human monocytes and lymphocytes differ in the rate of DNA repair synthesis and viability after exposure to nitrogen mustard.

R. Lewensohn, U. Ringborg, 2009, Acta medica Scandinavica.

Normal UV-induced DNA repair synthesis in peripheral leukocytes from patients with malignant melanoma of the skin.

U. Ringborg, B. Lambert, B. Lagerlöf, 1980, The Journal of investigative dermatology.

Chromosomal RNA synthesis in polytene chromosomes of Chironomus tentans

E. Egyházi, U. Ringborg, B. Daneholt, 2004, Chromosoma.

Role of O6-methylguanine-DNA methyltransferase, glutathione transferase M3-3 and glutathione in resistance to carmustine in a human non-small cell lung cancer cell line.

S. Egyházi, J. Hansson, M. Edgren, 1997, European journal of cancer.

Cis-diamminedichloroplatinum(II) toxicity in human melanoma cells and lymphocytes as related to cellular platinum accumulation, DNA cross-linking and inhibition of DNA synthesis.

R. Lewensohn, J. Hansson, U. Ringborg, 1988, Acta oncologica.

Managing cancer in the EU: the Organisation of European Cancer Institutes (OECI).

G. Storme, M. Pierotti, T. Tursz, 2008, European journal of cancer.

DNA-repair synthesis in blast cells from patients with acute myeloblastic leukaemia.

R. Lewensohn, U. Ringborg, 2009, Scandinavian journal of haematology.

The value of cysteinyldopa in the follow-up of disseminated malignant melanoma

U. Ringborg, B. Kågedal, C. Lindholm, 2000, Melanoma research.

Mutational analysis of the CDKN2 gene in metastases from patients with cutaneous malignant melanoma.

M. Inganäs, U. Ringborg, A. Platz, 1996, British Journal of Cancer.

Malignant melanoma of the vulva in a nationwide, 25‐year study of 219 Swedish females

L. Kanter‐Lewensohn, U. Ringborg, B. Ragnarsson-Olding, 1999, Cancer.

Low molecular weight RNA in cell components of Chironomus tentans salivary glands.

E. Egyházi, U. Ringborg, B. Daneholt, 1969, Journal of molecular biology.

Extraction and Fractionation of Low Molecular Weight RNA on the Microscale

E. Egyházi, U. Ringborg, B. Daneholt, 1968, Nature.

DNA repair synthesis in subpopulations of human lymphocytes.

R. Lewensohn, U. Ringborg, B. Lambert, 1982, Journal of cell science.

RNA synthesis in a Balbiani ring in Chironomus tentans salivary gland cells

E. Egyházi, U. Ringborg, B. Daneholt, 2004, Chromosoma.

Long-term survival in malignant melanoma with special reference to age and sex as prognostic factors.

U. Ringborg, R. Bergström, H. Adami, 1987, Journal of the National Cancer Institute.

Concentration and Time‐dependent Inter‐relationships for Cytotoxicities of Nitrogen Mustard Drugs against Lymphoblasts In‐vitro*

U. Ringborg, I. Wallin, H. Ehrsson, 1988, The Journal of pharmacy and pharmacology.

Differential DNA cross-linking and cytotoxicity in PHA-stimulated human lymphocytes exposed to melphalan, m-L-sarcolysin and peptichemio.

R. Lewensohn, J. Hansson, U. Ringborg, 1987, European journal of cancer & clinical oncology.

Inhibition of nitrogen mustard induced DNA repair synthesis by anthracyclines in human peripheral leukocytes.

R. Lewensohn, U. Ringborg, 1983, Cancer letters.

DNA-damage in human cells treated with the closely related alkylating agents peptichemio, m-L-sarcolysin and melphalan.

R. Lewensohn, U. Ringborg, I. Turesson, 1981, European journal of cancer & clinical oncology.

Increase of uv-induced DNA repair synthesis during blast transformation of human lymphocytes.

R. Lewensohn, U. Ringborg, D. Killander, 1979, Experimental cell research.

Incidence of uveal melanoma in Sweden from 1960 to 1998.

U. Ringborg, G. Lundell, S. Seregard, 2002, Investigative ophthalmology & visual science.

Pioneering quality assessment in European cancer centers: a data analysis of the organization for European cancer institutes accreditation and designation program.

W. V. van Harten, T. Tursz, U. Ringborg, 2014, Journal of oncology practice.

Improvement of European Translational Cancer Research. Collaboration between Comprehensive Cancer Centers

A. L. Bosch, W. V. van Harten, P. Riegman, 2008 .

Improvement of European translational cancer research. Collaboration between comprehensive cancer centers.

A. L. Bosch, W. V. van Harten, P. Riegman, 2008, Tumori.

Radiotherapy and Cancer Care in Sweden

U. Ringborg, T. Möller, N. Einhorn†, 2003, Acta oncologica.

Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: a clinic-based population study.

J. Hansson, U. Ringborg, A. Platz, 1998, International journal of cancer.

European Academy of Cancer Sciences-Designation of Comprehensive Cancer Centres of Excellence.

A. Berns, A. Eggermont, U. Ringborg, 2018, European Journal of Cancer.

U. Ringborg, B. Lambert, Lambert, 2006 .

Induction of unscheduled DNA synthesis in human bone marrow cells by bifunctional alkylating agents.

R. Lewensohn, U. Ringborg, 1979, Blood.

U. Ringborg, B. Lambert, L. Skoog, 1979 .

Interferon therapy in Hodgkin's disease. A case report.

K. Cantell, H. Strander, H. Blomgren, 2009, Acta medica Scandinavica.

Ultraviolet-induced DNA-repair synthesis in lymphocytes from patients with chronic lymphatic leukemia.

U. Ringborg, B. Lambert, 1977, Cancer letters.

Psychological reactions in public melanoma screening.

U. Ringborg, Y. Brandberg, P. Sjödén, 1993, European journal of cancer.

Electrophoretic characterization of nucleolar RNA from Chironomus tentans salivary gland cells.

E. Egyházi, U. Ringborg, B. Daneholt, 1970, Journal of molecular biology.

Agarose-Acrylamide Composite Gels for Microfractionation of RNA

E. Egyházi, U. Ringborg, B. Daneholt, 1968, Nature.

Microelectrophoretic Technique for Fractionation of RNA

U. Ringborg, B. Daneholt, B. Lambert, 1968, Nature.

Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma.

L. Hansson, J. Hansson, U. Ringborg, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic value of serum analyses of S‐100β protein in malignant melanoma

L. Hansson, J. Hansson, U. Ringborg, 1996 .

Serum S -100B P rotein a s a P rognostic M arker i n Malignant C utaneous M elanoma

J. Hansson, U. Ringborg, E. Schoultz, 2001 .

Inhibition of tumor cell growth by monoterpenes in vitro: evidence of a Ras-independent mechanism of action

A. Borg-Karlson, U. Ringborg, S. Linder, 1996, Anti-cancer drugs.

Induction of unscheduled DNA synthesis in human myeloma cells.

R. Lewensohn, U. Ringborg, 1980, Blood.

Prolonged increase of sister-chromatid exchanges in lymphocytes of melanoma patients after CCNU treatment.

U. Ringborg, B. Lambert, A. Lindblad, 1979, Mutation research.

Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: A report from the swedish melanoma study group

H. Adami, J. Wersäll, J. Hansson, 1993, Cancer.

Long term results of a randomized study by the Swedish Melanoma Study Group on 2‐cm versus 5‐cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm

C. Ingvar, U. Ringborg, P. Jönsson, 2000, Cancer.

The Swedish Council on Technology Assessment in Health Care (SBU) Systematic Overview of Radiotherapy for Cancer including a Prospective Survey of Radiotherapy Practice in Sweden 2001--Summary and Conclusions

Bengt Brorsson, Hans Svensson, Måns Rosén, 2003, Acta oncologica.

Decreased UV-induced DNA repair synthesis in peripheral leukocytes from patients with the nevoid basal cell carcinoma syndrome.

R. Lewensohn, U. Ringborg, B. Lambert, 1981, The Journal of investigative dermatology.

Tyrosinase activity in the serum of patients with malignant melanoma

B. Sonesson, E. Rosengren, U. Ringborg, 1995, Acta dermato-venereologica.

Uptake of [131I]thiouracil in tumours of patients with disseminated malignant melanoma. A pilot study

U. Ringborg, P. Schnell, B. Larsson, 1992, Melanoma research.

Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression.

L. Kanter, J. Hansson, U. Ringborg, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Trends in Incidence of Cutaneous Malignant Melanoma in a Swedish Population 1976-1994

U. Ringborg, H. Johansson, L. Rutqvist, 2002, Acta oncologica.

Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site

J. Hansson, U. Ringborg, A. Platz, 2008, Molecular oncology.

DNA repair and human disease.

U. Ringborg, B. Lambert, 2009, Acta medica Scandinavica.

DNA Repair in Some Cancer-Prone Conditions and in Patients with Cutaneous Malignancies

U. Ringborg, B. Lambert, 1980 .

A case report including EM and DNA repair investigations in a dermatosis associated with multiple skin cancers: epidermodysplasia verruciformis.

U. Ringborg, H. Hammar, L. Hammar, 2009, Acta medica Scandinavica.

NUCLEOLAR-DERIVED RIBONUCLEIC ACID IN CHROMOSOMES, NUCLEAR SAP, AND CYTOPLASM OF CHIRONOMUS TENTANS SALIVARY GLAND CELLS

U. Ringborg, L. Rydlander, 1971, The Journal of cell biology.

bifunctional alkylating agents Induction of unscheduled DNA synthesis in human bone marrow cells by

R. Lewensohn, U. Ringborg, 2011 .

[Normal UV-induced DNA repair synthesis in peripheral leukocytes in patients with malignant melanoma (proceedings)].

U. Ringborg, B. Lambert, 1978, Lakartidningen.

DNA repair replication, DNA breaks and sister-chromatid exchange in human cells treated with adriamycin in vitro.

R. Lewensohn, U. Ringborg, B. Lambert, 1983, Mutation research.

Absence of genotoxic effects of metronidazole and two of its urinary metabolites on human lymphocytes in vitro.

U. Ringborg, B. Lambert, A. Lindblad, 1979, Mutation research.

Decreased DNA repair synthesis in higher ages

U. Ringborg, B. Lambert, 1976 .

Induction and time course of DNA single-strand breaks in lymphocytes from patients treated with dacarbazine.

U. Ringborg, S. Walles, 1991, Carcinogenesis.

Effect of 5-fluorouracil on the cell growth and cell cycle kinetics of a mouse ascites tumor growing in vivo.

U. Ringborg, B. Tribukait, S. Skog, 1987, Acta oncologica.

O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma

S. Ma, J. Hansson, U. Ringborg, 2003, British Journal of Cancer.

Analysis of O6-methylguanine-DNA methyltransferase in melanoma tumours in patients treated with dacarbazine-based chemotherapy

S. Ma, J. Hansson, U. Ringborg, 2002, Melanoma research.

O6-methylguanine-DNA methyltransferase activities in biopsies of human melanoma tumours.

J. Hansson, U. Ringborg, S. Egyházi, 1995, British Journal of Cancer.

Carmustine-induced toxicity, DNA crosslinking and O6-methylguanine-DNA methyltransferase activity in two human lung cancer cell lines.

J. Bergh, P. Karran, J. Hansson, 1991, European journal of cancer.

Physico-chemical properties of chromosomal RNA in Chironomus tentans polytene chromosomes

E. Egyházi, U. Ringborg, B. Daneholt, 2004, Chromosoma.

Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes

U. Ringborg, A. Platz, B. Ragnarsson-Olding, 2002, Melanoma research.

Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.

P. Hofer, J. Hansson, U. Ringborg, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression.

L. Kanter, J. Hansson, U. Ringborg, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Translational Cancer Research: Balancing Prevention and Treatment to Combat Cancer Globally

C. Ulrich, P. Vineis, Z. Herceg, 2014, Journal of the National Cancer Institute.

Flow cytofluorometric DNA analyses of metastases of human malignant melanomas.

R. Lewensohn, J. Hansson, U. Ringborg, 1982, Analytical and quantitative cytology.

Original Paper Immunohistochemical Examination of the Expression of 06-methylguanine-DNA Methyltransferase in Human Melanoma Metastases

J. Hansson, U. Ringborg, S. Egyhizi, 1997 .

Immunohistochemical examination of the expression of O6-methylguanine-DNA methyltransferase in human melanoma metastases.

G. Margison, J. Hansson, U. Ringborg, 1997, European journal of cancer.

Adjuvant chemotherapy. A discussion of some basic principles.

U. Ringborg, 1991, Acta oncologica.

Evidence for genetic predisposition for some nasopharyngeal cancers by in vitro hyperdiploidy in human dermal fibroblasts.

M. Melamed, F. Traganos, U. Ringborg, 1987, Cancer genetics and cytogenetics.

In vitro hyperdiploidy in dermal fibroblasts: evidence for genetic predisposition in aerodigestive tract cancer

M. Melamed, F. Traganos, U. Ringborg, 1987, Clinical genetics.

Malignant Melanoma of the Vulva and Vagina: Trends in Incidence, Age Distribution, and Long-Term Survival Among 245 Consecutive Cases in Sweden, 1960–1984

U. Ringborg, H. Johansson, L. Rutqvist, 1994 .

Malignant melanoma of the vulva and vagina. Trends in incidence, age distribution, and long‐term survival among 245 consecutive cases in Sweden 1960–1984

U. Ringborg, H. Johansson, L. Rutqvist, 1993 .

INTRACELLULAR DISTRIBUTION OF LOW MOLECULAR WEIGHT RNA IN CHIRONOMUS TENTANS

E. Egyházi, U. Ringborg, B. Daneholt, 1971, The Journal of cell biology.

Optimizing sharing of hospital biobank samples

A. Broeks, P. Riegman, M. Daidone, 2015, Science Translational Medicine.

2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial

C. Ingvar, U. Ringborg, K. Drzewiecki, 2011, The Lancet.

Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: A randomized study by the Swedish Melanoma Study Group

U. Ringborg, P. Jönsson, H. Johansson, 1996, Cancer.

Prognostic factors in thin cutaneous malignant melanoma

U. Ringborg, J. Carstensen, L. Rutqvist, 1994, Cancer.

A Prospective Population‐Based Study of Cutaneous Malignant Melanoma of the Head and Neck

U. Ringborg, H. Johansson, J. Frisell, 2000, The Laryngoscope.

Evidence for transport of preribosomal RNA from the nucleolus to the chromosomes in Chironomus tentans salivary gland cells.

E. Egyházi, U. Ringborg, B. Daneholt, 1970, Journal of molecular biology.

Malignant melanoma of the vulva in a nationwide, 25‐year study of 219 Swedish females

L. Kanter‐Lewensohn, U. Ringborg, B. Ragnarsson-Olding, 1999, Cancer.

Chemotherapy resistance mechanisms.

U. Ringborg, A. Platz, 1996, Acta oncologica.

Allele losses in malignant melanoma reflect random events.

B. Werelius, U. Ringborg, M. Nordenskjöld, 1990, Anticancer research.

Proteinase K added to the extraction procedure markedly increases RNA yield from primary breast tumors for use in microarray studies.

J. Bergh, J. Bjöhle, A. Borg, 2004, Clinical chemistry.

Quantitative micro-assay for RNA-DNA hybrids in the study of nucleolar RNA from Chironomus tentans salivary gland cells.

E. Egyházi, U. Ringborg, B. Daneholt, 1973, Experimental cell research.

Comparison between chromosomal and nuclear sap RNA from Chironomus tentans salivary gland cells by RNA-DNA hybridization.

E. Egyházi, U. Ringborg, B. Daneholt, 1973, Experimental cell research.

Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.

S. Aamdal, C. Ingvar, U. Ringborg, 1998, European journal of cancer.

Dacarbazine versus dacarbazine-vindesine in disseminated malignant melanoma: A randomized phase II study

H. Strander, C. Rudenstam, J. Hansson, 1989, Medical oncology and tumor pharmacotherapy.

Methotrexate and 5-fluorouracil in head and neck cancer.

H. Strander, U. Ringborg, P. Lundquist, 1983, Seminars in oncology.

Radiation therapy in early glottic cancer. Analysis of 177 consecutive cases.

H. Strander, U. Ringborg, C. Silfverswärd, 1989, Acta oto-laryngologica.

Prognostic value of serum analyses of S-100 beta protein in malignant melanoma.

L. Hansson, J. Hansson, U. Ringborg, 1996, Melanoma research.

Prognostic value of serum analyses of S-100 protein beta in malignant melanoma.

L. Hansson, J. Hansson, U. Ringborg, 1997, Anticancer research.

Towards a cancer mission in Horizon Europe: recommendations

D. Hanahan, R. Bernards, H. Adami, 2020, Molecular oncology.

Adjuvant chemotherapy of malignant melanoma. A pilot study.

H. Strander, J. Hansson, U. Ringborg, 1985, American journal of clinical oncology.

CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas.

J. Hansson, U. Ringborg, J. Hashemi, 2000, Cancer research.

Advances in Brief CDKN 2 A Germline Mutations in Individuals with Multiple Cutaneous Melanomas 1

J. Hansson, U. Ringborg, J. Hashemi, 2000 .

Cancer risk in patients with earlier diagnosis of cutaneous melanoma In situ

U. Ringborg, T. Hakulinen, C. Wassberg, 1999, International journal of cancer.

The Porto European Cancer Research Summit 2021

S. Fröhling, D. Hanahan, J. Korbel, 2021, Molecular oncology.

The expression of glutathione transferase isoenzymes in human malignant lymphoma biopsies.

J. Hansson, X. Hao, B. Mannervik, 1995, Acta oncologica.

European Code Against Cancer and scientific justification: third version (2003).

H. Bartelink, R. Doll, M. Kogevinas, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group.

C. Ingvar, C. Rudenstam, U. Ringborg, 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cancer Core Europe: a consortium to address the cancer care-cancer research continuum challenge.

C. Caldas, R. Medema, O. Wiestler, 2014, European journal of cancer.

Preoperative radiation therapy of high malignancy grade soft tissue sarcoma. A preliminary investigation.

U. Ringborg, P. Jakobsson, U. Nilsonne, 1983, Acta radiologica. Oncology.

Treatment of carcinoma of the head and neck with combined irradiation and chemotherapy.

H. Strander, D. Bagger-sjöbäck, U. Ringborg, 1981, Acta radiologica. Oncology.

Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma

U. Ringborg, A. Platz, A. Höög, 1995, Melanoma research.

Metastatic patterns, clinical outcome, and malignant phenotype in malignant cutaneous melanoma.

U. Ringborg, L. Rutqvist, T. Singnomklao, 1999, Acta oncologica.

Postoperative radiotherapy following surgery for regional lymph node metastases in malignant melanoma: 343

J. Hansson, U. Ringborg, H. Johansson, 1993 .

A multicentre epidemiological study on sunbed use and cutaneous melanoma in Europe.

J. Coebergh, J. Cuzick, G. Severi, 2005, European journal of cancer.

Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome. A case-control study.

U. Ringborg, S. Seregard, M. Bergenmar, 1995, Ophthalmology.

Cytoplasmic and nuclear accumulation of β‐catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma

J. Hansson, U. Ringborg, A. Platz, 2001, International journal of cancer.

Sequential methotrexate–5‐fluorouracil treatment of squamous cell carcinoma of the head and neck

H. Strander, U. Ringborg, G. Ewert, 1983, Cancer.

Central nervous system metastases of cutaneous malignant melanoma--a population-based study.

U. Ringborg, H. Johansson, L. Rutqvist, 1998, Acta oncologica.

Effect of primary site on prognosis in patients with cutaneous malignant melanoma. A study using a new model to analyse anatomical locations

J. Hansson, U. Ringborg, J. Frisell, 2005, Melanoma research.

Glutathione transferase P1-1 expression in human melanoma metastases: correlation to N-RAS mutations and expression.

B. Mannervik, U. Ringborg, A. Platz, 1995, Acta oncologica.

Uveal melanoma survival in Sweden from 1960 to 1998.

U. Ringborg, G. Lundell, S. Seregard, 2003, Investigative ophthalmology & visual science.

Dacarbazine‐Vindesine‐Cisplatin in Disseminated Malignant Melanoma: A Phase I‐II Trial

H. Strander, J. Hansson, U. Ringborg, 1990, American journal of clinical oncology.

The effect of 5-fluorouracil on cisplatin induced DNA interstrand cross-linking in a mouse ascites tumor growing in vivo.

U. Ringborg, B. Tribukait, S. Skog, 1995, Anti-cancer drugs.

Sister chromatid exchanges in lymphocyte cultures of patients receiving chemotherapy for malignant disorders.

U. Ringborg, B. Lambert, A. Lindblad, 1978, Cancer treatment reports.

Trends in mortality from malignant melanoma in Sweden, 1970–1996

U. Ringborg, H. Johansson, L. Rutqvist, 2000, Cancer.

Early detection and prevention of cutaneous malignant melanoma: Emphasis on Swedish activities

U. Ringborg, A. Platz, M. Broberg, 1991, Medical oncology and tumor pharmacotherapy.

Nodular histogenetic type – the most significant factor for thick melanoma: implications for prevention

U. Ringborg, Y. Brandberg, M. Bergenmar, 1998, Melanoma research.

Outcomes of patients with local recurrence of cutaneous malignant melanoma

U. Ringborg, L. Rutqvist, G. Cohn-Cedermark, 1997, Cancer.

Treatment of keloids with surgical excision and postoperative X-ray radiation.

U. Ringborg, P. Hedén, O. Larson, 1989, Scandinavian journal of plastic and reconstructive surgery and hand surgery.

Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. The Swedish Lung Cancer Study Group.

O. Brodin, U. Ringborg, C. Mercke, 1996, European journal of cancer.

Melphalan-induced DNA cross-linking in human melanoma cells and phytohaemagglutinin-stimulated lymphocytes in relation to intracellular drug content and cellular levels of glutathione.

R. Lewensohn, J. Hansson, M. Edgren, 1987, Anticancer research.

Harmonizing cancer control in Europe.

U. Ringborg, 2006, Advances in experimental medicine and biology.

Factors responsible for bone marrow toxicity after treatment of myeloma patients with different alkylating agents.

R. Lewensohn, U. Ringborg, 2009, Acta Medica Scandinavica.

Psychological reactions in patients with malignant melanoma.

U. Ringborg, Y. Brandberg, P. Sjödén, 1995, European journal of cancer.

Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized phase III study.

U. Ringborg, O. Hansen, M. Overgaard, 1997, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cell cycle dependent sensitivity of human melanoma cells to melphalan is correlated with the activity and cellular concentration of glutahione transferases

X. Hao, B. Mannervik, U. Ringborg, 1994 .

Predictors of late mortality in cutaneous malignant melanoma—a population‐based study in Sweden

H. Adami, U. Ringborg, R. Bergström, 1996, International journal of cancer.

Development of light ion therapy at the Karolinska Hospital and Institute.

I. Näslund, U. Ringborg, H. Svensson, 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Cell cycle dependent sensitivity of human melanoma cells to melphalan is correlated with the activity and cellular concentration of glutathione transferases.

X. Hao, B. Mannervik, U. Ringborg, 1994, Carcinogenesis.

[Nevus or malignant melanoma? Correct diagnostic competence results in lower costs].

U. Ringborg, Ulrik Ringborg, B. Lindelöf, 2008, Lakartidningen.

Further evidence for increased light sensitivity in patients with malignant melanoma

H. Beitner, U. Ringborg, G. Wennersten, 1981, The British journal of dermatology.

Psychological effects of participation in a prevention programme for individuals with increased risk for malignant melanoma.

U. Ringborg, Y. Brandberg, C. Bolund, 1992, European journal of cancer.

Information to patients with malignant melanoma: a randomized group study.

U. Ringborg, Y. Brandberg, P. Sjödén, 1994, Patient education and counseling.

Formation and processing of ribonucleic acid in subnuclear components of Chironomus tentans.

E. Egyházi, U. Ringborg, B. Daneholt, 1969, Biochemical Journal.

RNA Synthesis in a Balbiani Ring in Chironomus tentans

E. Egyházi, U. Ringborg, B. Daneholt, 1970 .

Expression of class-pi glutathione transferase in drug-resistant human-melanoma cells

J. Hansson, B. Mannervik, U. Ringborg, 1987 .

Different melphalan toxicity and DNA cross-linking in human melanoma cells as compared to phytohaemagglutinin-stimulated lymphocytes.

R. Lewensohn, J. Hansson, U. Ringborg, 1985, Anticancer research.

Cutaneous Malignant Melanoma

U. Ringborg, Temple Wj, 2006 .

EurocanPlatform, an FP7 project of the European Commission—first year commentary

U. Ringborg, G. Mcvie, 2012, Ecancermedicalscience.

Mutational analysis oftheCDKN2 geneinmetastases frompatients with cutaneous malignant melanoma

U. Ringborg, E. Lundqvist, B. Lagerlöf, 1996 .

[The Open House campaign for skin examinations resulted in valuable experiences].

H. Beitner, U. Ringborg, H. Rorsman, 1992, Läkartidningen.

'Children under the Sun'-- UV radiation and children's skin. WHO Workshop -- Children's sun protection education.

A. McKinlay, U. Ringborg, E. Breitbart, 2002, European Journal of Cancer Prevention.

Composition and content of RNA in neurons of rat hippocampus at different ages.

U. Ringborg, 1966, Brain research.

Contralateral primary tumors in breast cancer patients in a randomized trial of adjuvant tamoxifen therapy.

L. Skoog, U. Ringborg, L. Rutqvist, 1991, Journal of the National Cancer Institute.

Cytotoxicity and DNA cross-linking induced by peptide conjugated m-L-sarcolysin in human melanoma cells.

R. Lewensohn, J. Hansson, U. Ringborg, 1991, Anticancer research.

Increased toxicity and DNA cross-linking by peptide bound m-L-sarcolysin (Peptichemio) as compared to melphalan and m-L-sarcolysin in human melanoma cell lines.

R. Lewensohn, J. Hansson, U. Ringborg, 1991, Anticancer research.

2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial

C. Ingvar, U. Ringborg, K. Drzewiecki, 2011, The Lancet.

Epstein‐barr virus‐specific serodiagnostic tests in carcinomas of the head and neck

H. Strander, G. Klein, U. Ringborg, 1983, Cancer.

Engaging European society at the forefront of cancer research and care

L. Maier-Hein, M. Boutros, E. Weiderpass, 2023, Molecular oncology.